India Considers Treating NNDS Changes As New Drugs Needing Trials
This article was originally published in PharmAsia News
Executive Summary
India drug regulators are considering a change in the Drugs and Cosmetics Act to classify existing drugs that add delivery systems as new drugs that would need to conduct clinical trials before getting marketing approval.